Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
age-related macular degeneration
MedTech
Alcon to buy LumiThera’s light-based therapy for dry AMD
LumiThera's approach employs different wavelengths of low-level light to help stimulate mitochondrial activity in the cells of the retina.
Conor Hale
Jul 8, 2025 10:30am
NIH creates eye drops that protect mice from vision loss
Mar 25, 2025 3:10pm
Eye disease biotech looks to clinical trials with $93M series B
Mar 25, 2025 8:00am
Outlook lays off 23% of staff as it eyes FDA approval, EU debut
Dec 16, 2024 8:25am
AlloVir finds new identity via eye disease biotech merger
Nov 8, 2024 9:05am
FDA clears first treatment for dry AMD, with LumiThera's Valeda
Nov 6, 2024 10:30am
